XKRX

Across TCGA pan-cancer cohorts, XKRX Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated XKRX data layer compared with 22 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher XKRX Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated XKRX expression acts as an unfavorable survival marker, although some lineages such as LGG and UCEC show a favorable association.

HNSC, OV, and SKCM are the cancer types where XKRX Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.231	0.722	<.001	34	view →
OV	DFS	Median	All	0.165	0.541	.004	18	view →
SKCM	DFS	Median	All	0.152	0.761	<.001	18	view →
BLCA	OS	Median	III,IV	0.132	0.684	<.001	12	view →
LGG	OS	Median	All	1.000	0.413	.032	4	view →
UCEC	DFS	Median	All	0.961	0.627	.023	4	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

XKRX–HNSC (OS)

Open the HNSC breakdown →